While most CAF subtypes are studied in their cancer-promoting functions, the discovery of cancer-restraining CAFs (rCAFs) in PDAC, which are defined by the expression of Meflin, complicates our understanding of the role of fibroblasts in cancer. This evidence concerns the gene ISLR and cancer.